Moderna
MRNA
#893
Rank
NZ$48.96 B
Marketcap
NZ$123.41
Share price
3.61%
Change (1 day)
172.51%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -NZ$5.32 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$2.20 Billion. In 2025 the company made an earning of -NZ$4.89 Billion, an increase over its 2024 earnings that were of -NZ$6.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$5.32 Billion8.89%
2025 -NZ$4.89 Billion-23.03%
2024 -NZ$6.35 Billion-8.22%
2023 -NZ$6.92 Billion-140.65%
2022 NZ$17.00 B-27.81%
2021 NZ$23.55 B-1911.15%
2020 -NZ$1.31 Billion44.7%
2019 -NZ$0.9 Billion28.63%
2018 -NZ$0.7 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.99 B-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.94 B-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$23.28 B-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-NZ$83.98 Million-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$73.95 Million-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.53 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$0.61 B-111.09%๐Ÿ‡บ๐Ÿ‡ธ USA